Point-Of-Care Breathalyser Market Foresees US$ 658.9 Million by 2032 with a 5.5% CAGR | Future market Insights,Inc.

The demand for point-of-care breathalysers market is expected to reach US$ 385.7 million in 2022, and from 2022 to 2032, it is projected to grow at a CAGR of 5.5% to reach US$ 658.9 million. The growth is ascribed to rising alcohol intake. The point-of-care breathalyser market saw a compound annual growth rate (CAGR) of 5.2% from 2016 to 2021.

Breathalyzer is a non-invasive medical device used for estimation of Blood Alcohol content (BAC) from breath sample. Breathalyzer is used to test intoxication levels caused by alcohol and drugs. Breathalyzer was invented by Dr. Robert Borkenstein while being appointed as police photographer at Indiana State Police lab.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2286

Since 1954, Breathalyzer is a genericized trademark for many instruments like Alcotest, Alcosensor, Datamaster, Intoxilyzer and Intoximeter. Breathalyzer device consists of three parts, first part consists of system where breath is sampled, second part consists of two glass tubes with chemicals and third part consists of photocells that are connected to meter showing colour change.

Breathalyzer system together works on redox reaction causes change in colour that is directly proportional to amount of alcohol in breath, wherein red-orange colour of dichromate ion changes to green.

Breathalyzer has been of importance in point-of-care services where initially it was necessary to draw blood out of the body and sent to the hospital to test alcohol concentration in blood, thus making the test time consuming. Till date it has been most important device to monitor and regulate drink and drive accidents or cases.

In 2015 in US, there were about 290,000 people injured and about 10,265 died in drunk driving cases. Also there have been published reports on loss of work quality and time due to alcohol consumption. All over the world it is a legal offense to be detected of alcohol during working hours and while driving.

The driver is charged fine or respective legal action is taken against him if his Blood Alcohol Concentration (BAC) is found out to be above normal (0.08). Also strict actions are taken against employees in government or private sectors if they are detected of alcohol consumption during office hours.

Due to use of Breathalyzer there is no need of any invasive procedure, device is portable and test results are out in seconds. Another important use of Breathalyzer is in maintaining high order discipline in National and International air transport to maintain safety and standards while travelling.

Breathalyzer is of very significant use to prevent order and discipline in government or private offices, road traffic management and forensic studies too. It is also used for management in rehabilitation centres, mining and construction centres.

Point-of-Care Breathalyzer Market: Drivers and Restraints

Point-of-care Breathalyzer market has seen enormous growth due to its significant use to maintain safety, order and discipline amongst population. The major drivers for point-of-care Breathalyzer market is alarming increase in alcohol consumption seen at all age groups and also increase in road accidents due to drink driving.

Due to strict government regulations, drink driving and alcohol abuse during work hours has led to increase in demand for modern use portable Breathalyzer. Use of personal portable Breathalyzer to check for alcohol content within normal limits to keep a check on safe driving and productive working hours has given a drive for point-of-care Breathalyzer market worldwide.

Moreover easy availability of personal Breathalyzer that can be ordered online according to ones choice, has also been a factor to drive point-of-care Breathalyzer market. Awareness initiative taken by government has also led to increase of market size for point-of-care Breathalyzer market.

High cost of Breathalyzer and less market for new brands producing Breathalyzer were seen to hamper in the past for but modern portable cheap Breathalyzer are taking over the point-of-care Breathalyzer market now.

Point-of-Care Breathalyzer Market: Overview

According to a study report published in South Africa about 10% of the country’s GDP is lost due to alcohol abuse annually which is equal to R240 billion. Also worldwide there is much loss due to alcohol abuse leading to immense destruction in drunk driving accidents, expensive alcohol abuse treatment and loss of manpower and productive working hours brings an overall effect on worldwide economy.

Thus awareness due to such losses have led government to take strict measures in field of law enforcement and highway safety administration to bring down losses. Efficient use of point-of-care Breathalyzer to prevent such loss has proved beneficial and made people aware of its legal consequences being the reason for increasing market for of point-of-care Breathalyzer market.

Mandatory alcohol test are carried out worldwide in workplaces such as transport, construction sites mining, shipping, airlines, defense centres, rehabilitation centres to maintain safety of individuals increasing market size for point-of-care Breathalyzer market over globe.

Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-2286

Point-of-Care Breathalyzer Market: Key Players

Some of the key players in point-of-care Breathalyzer market include Drägerwerk AG & Co. KGaA, Intoximeters,Lion Laboratories Limited, Lifeloc Technologies, Inc., Inc., , BACtrack, Quest Products, Inc., Alere, Inc., and C4 Development, Andatech Private Limited Ltd. Most of the providers of point-of-care breathalyzer are adopting the strategy of providing these products through e-commerce, so that buyers can browse the products according to their needs.

Based on product type, the point-of-care breathalyzer market is segmented into the following:

  • Desktop Point-of-Care Breathalyzer
  • Portable Point-of-Care Breathalyzer
  • Handheld Point-of-Care Breathalyzer

 Based on product technology, the point-of-care breathalyzer market is segmented into the following:

  • Chemical reaction (Breathalyzer).
  • Fuel-cell technology (Alcosensor III or IV).
  • Infrared Spectroscopy (Intoxilyzer).

Based on end user, the point-of-care breathalyzer market is segmented into the following:

  • International and National transport systems.
  • Rehabilitation centres.
  • Government and private offices.
  • Diagnostic centers.
  • Home care settings

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Intelligent Prosthetics Industry is expected to see growth, reaching US$ 1,437.6 Million by 2033 | FMI

By the end of 2023, the intelligent prosthetics industry is anticipated to be worth US$ 791.5 million, and it will grow at a CAGR of 6.1% to reach an estimated US$ 1,437.6 million by the year 2033. Lower extremity prosthetics by-products are expected to dominate the market in 2022 with a share of roughly 64.4%, according to a recent study.

Artificial intelligence is expected to be used in the futuristic design of intelligent prosthetics. Annually, 1 million global new amputees, i.e., one amputation every 30 seconds, suffer the loss of a limb. This means that they have to adapt to a new world.

Request A Sample Copy Of This Research Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-15497

India, for instance, is one of the world’s most highly populated countries. Merely 3% of its buildings have been equipped with accessibility, whereas the country has a total of +50,000 amputees. Due to the new adaptation process, amputees also fall victim to many injuries.

An increasing number of amputees and their susceptibility to injuries have been surging the demand for intelligent prosthetics in emerging countries like India. Amputations are also caused by surging cases of vascular diseases and trauma and aging populations. These statistics are expected to increase across the world.

Countries like the United States are expected to observe nearly double the cases of amputees by 2050. Consequently, pushing the demand for intelligent prosthetics. High-income levels of American residents and the well-established medical sector are also expected to have a positive influence on the region.

In March 2020, the University of Michigan, in its publication of Science Translational Medicine, documented a new way of incorporating this technology with several varieties of prostheses. Thus, helping the market advance over the forecast period.

Top Highlights from the FMI’s Analysis of the Intelligent prosthetics industry:

  • Due to intelligent prosthetics’ well-established market in North America, the region’s stake ranks at the top. FMI has estimated that the regional market is expected to acquire 40.6% in 2022.
  • In North America, the United States is projected to gain a terrific share over the forecast period. The country’s share on the global scale has been assessed to be 34.7% in 2022.
  • The Europe region is another dominant region with a share of more than 30% over the forecast period. Also, manufacturers have already pounded on the business opportunities present in the region. The estimated trend is expected to witness the same ongoing trend.
  • Germany’s sizeable share in the region is heavily influencing the region’s value share. In 2022, Germany’s market occupied a 6.9% value share.
  • Japan’s market is expected to accrue a market share of above 4% in 2023.
  • China is expected to gain a notable CAGR of 8.1% over the forecast period.
  • From 2023 to 2033, India’s market is projected to register a CAGR of 6.5%.
  • Australia’s CAGR is estimated to be 5.4%; meanwhile, the United Kingdom’s CAGR is projected to be 4.8%.
  • Based on product, the lower extremity prosthetics segment accounted for 64.4% in 2022.
  • Under the distribution channel category, the prosthetic clinics segment gained a market share of 43.1% in 2022.

Our Analyst Is Here To Assist You With Any Questions Get In Touch Now! https://www.futuremarketinsights.com/ask-question/rep-gb-15497

Leading Companies in the News:

  • ISRO made a smart artificial limb in September 2023 that enables above-knee amputees to move about in a comfortable gait. The artificial limb is equipped with 1.6 kg MPK that supports an amputee to walk 100 meters in the corridor with the least amount of support. The “microprocessor-managed knees” (MPKs) provide the amputee capacity in comparison to passive limbs that don’t deploy microprocessors.
  • Ecole Polytechnique Federale De Lausanne research institute in Switzerland made a prosthetic hand that employs artificial intelligence to get used to the user’s finger movement and improves amputee comfort.
  • The Massachusetts Institute of Technology created an intelligent prosthetic in 2018. The product was made with the user-body weight and at a cost-friendly price for amputees within the United States.

Key Companies Profiled:

  • Sarcos Technology and Robotics Corporation
  • Ktwo Healthcare Pvt. Ltd.
  • Touch Bionics Inc.
  • HDT Global
  • SynTouch, Inc.
  • Artificial Limbs & Appliances
  • Ottobock
  • Ossur Americas
  • Blatchford Group
  • Manta Product Development

Empower Your Business with Customization: Discover the Strategies in Our New Report! https://www.futuremarketinsights.com/customization-available/rep-gb-15497

Key Market Segments Covered in Intelligent Prosthetics Industry Research:

By Product:

  • Upper Extremity
  • Lower Extremity

By Distribution Channel:

  • Hospitals
  • Prosthetic Clinics
  • Rehabilitation Centre
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Navigating the US$ 15,247 Million Anti-Pollution Skin Care Products Market Revolution with a 6% CAGR by 2033 | FMI

The anti-pollution skin care products market is predicted to be valued at US$ 7,511.6 million in 2023 and US$ 15,247 million by 2033. Over the projection period, sales in the anti-pollution skin care products market are expected to increase at a CAGR of 7.3%.

A potential trend in the anti-pollution skin care products market is the rising demand for multifunctional products that not only protect against pollution but also offer additional benefits like hydration and anti-aging properties.

Explore the Booming Market with Our Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13793

This convergence of functionalities presents a promising avenue for market players to explore. Another emerging trend is the customization of anti-pollution skincare, as consumers seek personalized solutions tailored to their specific needs and environmental conditions. This opens doors for innovative formulations and customizable product lines.

The market has yet to fully leverage the potential of digital technologies. Embracing e-commerce platforms, social media engagement, and virtual consultations can enhance brand visibility and create unique customer experiences. The demand for sustainable and eco-friendly packaging is gaining traction, presenting an opportunity for companies to align with environmentally conscious consumers.

Expanding market reach to untapped regions and demographics holds great potential. Educating consumers about the importance of pollution protection and targeting emerging markets with increasing pollution levels can drive market growth. Overall, the anti-pollution skin care products market is poised for exciting and unexplored opportunities, awaiting those bold enough to seize them.

Request Our Methodology to See How We Conducted Our Study: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-13793

Key Takeaways from the Market:

  • By 2023, India is projected to dominate the South Asian market, representing more than 24.5% of the market share.
  • The market share of South Korea in East Asia is estimated to exceed 12.6% by 2023.
  • According to the analysis, women are expected to hold a significant share of 37.5% among end-users during the forecast period of 2023.
  • The natural/organic segment is anticipated to experience a noteworthy compound annual growth rate (CAGR) of 9.2% throughout the predicted period.
  • Sun care products take the lead, accounting for 28.8% of the market share in 2023.

How Key Players are revolutionizing the Manufacturing of Anti-Pollution Skin Care Products market?

Prominent players in the manufacturing of anti-pollution skincare products are spearheading a revolution. Through innovative techniques, cutting-edge research, and consumer insights, they are transforming the market. By harnessing advanced technology and natural ingredients, they create potent formulas that shield against environmental aggressors.

Collaborations with experts and scientists enable them to develop effective solutions. Embracing sustainable practices, they prioritize eco-friendly packaging and reduce their carbon footprint. Their commitment to quality and safety ensures products that meet regulatory standards. With impactful branding and strategic marketing, they educate consumers about the importance of protecting skin from pollution. Through these efforts, leading players drive the evolution of the anti-pollution skincare industry.

Key Players in the Market:

  • Beiersdorf AG
  • Shiseido Company
  • Amway
  • Unilever PLC
  • The Estée Lauder Companies Inc.
  • L’Oréal S.A.
  • Kao Corporation
  • Colgate-Palmolive Company
  • Procter & Gamble Co.
  • Avon Products, Inc.
  • Others

Product Portfolio:

  • The Estée Lauder Companies Inc.: The Estée Lauder Companies Inc. offers a diverse product portfolio that includes renowned skincare, makeup, fragrance, and hair care brands such as Estée Lauder, Clinique, MAC, Origins, Aveda, and Jo Malone, catering to a wide range of beauty preferences and needs.
  • L’Oréal S.A.: L’Oréal S.A. boasts an extensive product portfolio encompassing skincare, hair care, makeup, and fragrance brands. Its portfolio includes popular brands like L’Oréal Paris, Maybelline New York, Garnier, Lancôme, Kiehl’s, and Redken, providing comprehensive beauty solutions for diverse consumer segments worldwide.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Sphingolipids Market is Reaching a Noteworthy US$ 991.8 Million by 2032 | Future Market Insights,Inc.

The global sphingolipids market was valued at approximately US$ 564.0 million in 2021, according to Future Market Insights’ most recent industry analysis. The market is expected to grow at a compound annual growth rate (CAGR) of nearly 5.1% during the forecast period, reaching an estimated valuation of US$ 991.8 million in 2032.

The global market for sphingolipid products is expanding rapidly as a result of rapid molecular and biological customization in the sphingolipid components/ formulations and the increasing prevalence of cardiovascular diseases worldwide coupled with an elderly population.  During the forecast period, the market is anticipated to be driven by an increase in the use of natural, synthetic, and semi-synthetic sphingolipids and monomers in the creation of various pharmaceutical formulations.

As the sphingolipids market is not reaching its potential as per the asked demand, due to unexplored benefits of sphingolipids in the healthcare sector, and the side effects of the consumption of sphingolipids inappropriately, the companies are introducing novel sphingolipids components/formulations with minimal side effects at reasonable costs.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15713

This factor might significantly improve the adoption and consumption of pharmaceutical sphingolipids. The rising product launches and approvals are expected to contribute to the market growth over the forecast period too.

Key Takeaways from Market Study:

  • Sphingomyelin is the leading segment as a product and holds approximately 0% market share in 2021, due to its anti-cancer, bacteriostatic, and cholesterol-lowering characteristics.
  • Synthetic sphingolipids are the leading segment by source, and held about 4% market share in 2021, owing to their potential as therapeutic prospects for treating a range of medical problems.
  • Conventional lipid-based drug delivery systems (LBDDS) is the leading segment in terms of application holding about 9% of the market share, as compared to traditional tablets or powder-filled capsules, as they can improve bioavailability and reduce dissolving rate-limited absorption because of their pharmacological composition in a solubilized condition.
  • Semi-solid form of sphingolipids is the leading form as of 2021, withholding about 3% of the global market share, owing to the property of reduced adverse side effects when a high drug load is applied to the area where the medication is actually required.
  • Pharmaceutical companies are the leading end users of the global market as of 2021, withholding about 5% of the market share, because of increased outsourcing, innovative modalities, and creative patient outreach tactics.
  • By region, North America is leading in the global sphingolipids market and is expected to continue to do so with a projected CAGR of 4% during the forecasted years.

“Rising initiatives to promote health benefits of sphingolipids products, as well as the increasing ongoing research and development in modifying novel sphingolipids formulations is set to propel the market of sphingolipids across the globe,” says an analyst of Future Market Insights.

Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-15713

Market Competition

Companies are actively working to increase their market share in this industry by forming strategic agreements to diversify their respective service offerings and sphingolipid production capacities.

  • In January 2022, Pfizer and Acuitas Therapeutics reached an agreement on Lipid Nanoparticle Delivery System for mRNA vaccines and therapeutics.
  • June 2022: To support customers’ scientific research, CD Bioparticles, enlarged its lipid system portfolio and introduced a number of Sphingolipids products. With the addition of Phosphosphingolipids, Ceramides, Sphingolipid Metabolism, Sphingosines, Glycosphingolipids, Phytosphingosine, and Sphingomyelin, researchers now have more options to choose from and employ in lipid system applications.

Key Companies Profiled

  • Merck KGaA
  • CordenPharma International
  • Lipoid GmbH
  • LARODAN AB
  • Croda International Plc.
  • Biosynth, Santa Cruz Biotechnology, Inc.
  • Creative Enzymes
  • CD Bioparticles
  • Cayman Chemical Company
  • Biosolve BV

Ask the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15713

Key Segments Covered In Sphingolipids Industry Research

By Product:

  • Ceramide
  • Sphingomyelin
  • Glucosylceramide (GlcCer)
  • Lactosylceramide (LacCer)
  • Ganglioside GM3
  • Other

By Source:

  • Synthetic
  • Semi-synthetic
  • Natural

By Application:

  • Conventional Lipid-based Drug Delivery Systems (LBDDS)
  • Self-Emulsifying Drug Delivery Systems (SEDDS)
  • Self-Microemulsifying Drug Delivery Systems (SMEDDS)
  • Liposomes
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Others

By Form:

  • Liquid
  • Semi-solid
  • Solid

By End User:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Academics and Research Institutes
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Pharma and Healthcare Social Media Marketing Market Surges with a Projected CAGR of 17.5% to Reach US$ 55,500.0 Million by 2032

The demand for pharmaceutical and healthcare social media marketing market is expected to increase significantly over the next decade. It is projected to grow at a Compound Annual Growth Rate (CAGR) of 17.5% from 2022 to 2032, reaching a total value of approximately US$ 55,500.0 Million by 2032. When stakeholders in the pharmaceutical and healthcare industries reach out to potential customers through digital, social media platforms in today’s digital age, pharma and healthcare social media marketing is a topic that is extremely relevant.

Pharma and healthcare social media marketing is a topic that is extremely relevant in today’s digital age, when stakeholders in the pharmaceutical and healthcare industries are reaching out to potential customers via digital, social media platforms.

Request for a Sample of this Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-403

The global market for pharma and healthcare social media marketing services is booming in the information age, as almost all the stakeholders in the pharma and healthcare industries are emerging in the world of social media to market their products, mainly because their potential customers are spending most of their time on social media.

Though social media tools are proving highly effective for the marketing of pharma and healthcare products in the world of customer-centric business, their use is still a matter of debate among end users.

Nevertheless, the overall growth of the global market for pharma and healthcare social media marketing services is expected to witness astonishing growth in the coming years, as a majority of businesses are taking their operations digitally.

Leading players in the market are increasing their focus on crafting creative marketing campaigns to help their customers gain a competitive advantage through more effective interaction and engagement with their target audience consistently.

Involvement of Regulatory Bodies may Restrict the Scope of Social Media Marketing for Pharma and Healthcare Companies

The pharma and healthcare sector is subjected to various rules and regulations regarding the marketing of medical and pharmaceutical products, and this scenario also follows in the planning of social media marketing strategies for these companies.

Governing bodies are modifying their traditional regulatory restrictions on the advertising of drugs and other marketing innovations in the pharma and healthcare industries.

Involvement of regulatory bodies in the global market for pharma and healthcare social media marketing is mainly in the areas of crafting and issuing guidelines in advertising of drugs and biologists through interactive media.

Various policies along with laws and regulations play an instrumental role in deciding the importance and effectiveness of social media in the marketing of pharma and healthcare products, though it restricts the scope of marketing campaigns.

For instance, the United States Food and Drug Administration (FDA) released new guidelines in January 2014, for the pharmaceuticals and healthcare industries defining the regulatory requirements vis-a-vis the marketing submissions for human and animal drugs across social media platforms.

Through its draft, the FDA also clarified various guidelines for content creators and marketers working in the pharmaceutical and healthcare marketing industry while working on the dissemination of branded information about drugs and biologics.

Pharma and Healthcare Social Media Marketing Market: Competitive Landscape

  • Digital Healthcare
  • Sermo
  • MomMD
  • Student Doctors Network
  • QuantiaMD
  • Doximity
  • Healthcare and Medical Software
  • Orthomind
  • WeMedUp
  • Medical Apps
  • DoctorsHangout
  • Nurse Zone
  • All Nurses
  • Medical Doctors
  • Ozmosis

Other pharma and healthcare companies that are highly engaged in social media marketing include Novartis, Johnson & Johnson, Pfizer, Inc., Novo Nordisk, and Bayer AG.

Seize this Opportunity: Buy Now for a Thorough Report
https://www.futuremarketinsights.com/checkout/403

Key Segments Covered in the Pharma and Healthcare Social Media Marketing Industry Analysis

By Social Media Platform:

  • YouTube
  • Twitter
  • Instagram
  • Facebook

By End User:

  • Healthcare Professionals
  • Hospitals
  • Biotechnology Companies
  • Patients/Consumers

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Palliative Care Market Envisions US$ 28,518.5 Million Valuation by 2032 | Future Market Insights,Inc.

In 2022, the global Palliative Care Market is expected to be worth US$ 13,087.9 million. Palliative care is given to patients suffering from diseases such as cancer, congestive heart failure (CHF), CNS disorders, chronic pulmonary obstructive disease (COPD), and others, and it includes symptomatic relief for nausea and vomiting, diarrhoea, pain and anxiety, loss of appetite, and other symptoms. The overall demand for Palliative Care is expected to grow at a 7.3% CAGR between 2022 and 2032, reaching approximately US$ 28,518.5 million by 2032.World Health Organization (WHO) defines palliative care as an approach to improve the quality of life of a patients and their families who are facing difficulties related to the fatal illness by providing a treatment for relieving the symptoms of an underlying disease/disorder. Whereas, Hospice care is a specific type of palliative care procedure to help the terminally ill patients to make their final months/days of life soothing and less painful. Palliative care is provided to patients suffering from diseases such as cancer, congestive heart failure (CHF), CNS disorders, chronic pulmonary obstructive disease (COPD) and others, providing symptomatic relief for nausea & vomiting, diarrhea, pain & anxiety, loss of appetite and many more. International Association for Hospice and Palliative Care (IAHPC) have listed 32 essential medicines for the hospice and palliative care, including analgesics, antiemetic etc. Palliative care concentrates on furnishing patients with the alleviation of the side effects, stress, and worry of a genuine sickness irrespective of the diagnosis. The objective is to enhance personal satisfaction for both the patient and the family. Palliative care is given by a group of doctors, specialists, medical caretakers, and different masters, who cooperate with a patient’s different specialists to give an additional layer of help. It is fitting at any age and at any phase in a genuine ailment, and can be furnished alongside remedial treatment.Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5522

Palliative Care Market: Overview

The global market for palliative care is expected to flourish over the forecast period of 2017-2027 due to increasing awareness about physical, social and psychological, needs of patients with life-threatening diseases and their families. Majority of people receiving hospice care are the cancer patients, according to WHO.

Palliative Care Market: Region-wise Overview

Geographically, the global market for palliative care is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to take greater share in global palliative care market because of good reimbursement and insurance coverage for palliative care services. Countries like Mexico in the Latin American region have more number palliative care centers for children.

Some of the key players and healthcare service providers in global palliative care market are: Center to Advance Palliative Care (CAPC), UCLA Health, National Hospice and Palliative Care Organization, VITAS Healthcare, CHI Franciscan, University of Washington (UW Medical Center & UW Medicine), Seymour Health, KEHPCA (Kenya Hospices and Palliative Care Association) & others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Unlock exclusive insights with our expert analysts :
 https://www.futuremarketinsights.com/ask-question/rep-gb-5522

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Palliative Care Market: Segmentation

The global palliative care market has been classified on the basis of service type, end user and geography.

Based on service type, the global palliative care market is divided into following:

  • Private residence care
  • Hospice inpatient care
  • Hospital inpatient care
  • Nursing home and residential facility care
  • Others

Based on end user type, the global palliative care market is divided into following:

  • Hospitals
  • Home Care Settings
  • Palliative Care Centers
  • Long Term Care Centers & Rehabilitation Centers

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

Insights Designed for You: Customize Your Exclusive Report Today :
https://www.futuremarketinsights.com/customization-available/rep-gb-5522

Key Segments Covered in the Palliative Care Industry Analysis

By Service Type:

  • Private Residence Care
  • Hospice Inpatient Care
  • Hospital Inpatient Care
  • Nursing Home and Residential Facility Care
  • Others

By End User:

  • Hospitals
  • Home Care Settings
  • Palliative Care Centers
  • Long-Term Care Centers & Rehabilitation Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Projected Growth: Calcium Sulfate Industry Set to Reach US$ 338.54 Billion by 2033

In 2023, the calcium sulfate market is expected to be worth US$ 266.84 billion, and by 2033, It is expected to reach US$ 338.54 billion. Calcium sulfate sales are expected to grow at a CAGR of 4.1% over the forecast period.

The melting point of calcium sulfate is 1,400°C. It is a white, odorless powder. In nature, it can be found as both a hydrated and anhydrous powder. Calcium sulfate can be found in a variety of forms, including selenite, satin, light spar, terra alba, and satinite. When calcium sulfate is heated, a considerable amount of water molecules are released, resulting in plaster of Paris (POP).

POP hardens into a mass when mixed with water and can be used to manufacture plaster casts, wall plasters, and other items. Furthermore, calcium sulfate is used as a drying agent in laboratories, a coating agent in the paper industry, a color pigment in paintings, and a soil conditioner in agriculture.

The rise in the use of calcium sulfate in construction products such as rapid setting cement, plaster of Paris, and wall plasters is the primary factor driving the growth of the worldwide calcium sulfate market. It is also commonly used in dental offices as a tool for generating casts or dental imprints, which aids market growth.

Access Your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4038

The rising pulp and paper industry is driving demand for calcium sulfate, which is used as a surface sizing agent and a pigment to generate coated paper with high brightness and whiteness. Furthermore, the market is expected to expand at a quicker rate due to an increasing demand for calcium sulfate as a calcium supplement that is necessary for cell and bone formation.

The market is also expected to grow due to an increase in the use of calcium sulfate as a desiccant and an inactive component in pharmaceuticals. The rapidly expanding applications across numerous end-use sectors, as well as rising demand from emerging nations, are expected to provide potential development chances for market expansion.

Given the increasing demand for calcium sulfate in emerging markets such as China and India, the Asia-Pacific region held the largest market share for calcium sulfate in 2022 and is expected to maintain that position in the future. China is expected to maintain its dominance in the calcium sulfate market over the forecast period. This is due to the country’s expanding building industry. The demand for calcium sulfate as an additive, reducing agent, and drying agent is expected to expand over the anticipated period, and this is proving to be a key driver of calcium sulfate market expansion in this region.

KEY TAKEAWAYS

  • The market in the United States has grown significantly in 2022 holding a 10.7% share of the global market.
  • The market in China is expected to grow at a CAGR of 4.1% over the forecast period.
  • The market in the United Kingdom is anticipated to grow at a CAGR of 2.7% through 2033.
  • With a CAGR of 5.8% over the forecast period, India is predicted to grow rapidly in the market.
  • Germany accounted for 3.8% of the global market in 2022.

Get Instant Access to the Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-4038

COMPETITIVE LANDSCAPE

The top manufacturers of the calcium sulfate market are USG Corporation, Solvay SA, Honeywell International Inc., Beijing New Building Materials PLC, Penta Manufacturing Company, Boral Limited, Compagnie de Saint-Gobain SA, YOSHINO GYPSUM CO., LTD., JONOUB GYPSUM, PABCO Building Products, LLC, Celtic Chemicals Limited, Georgia-Pacific LLC, and among others.

To meet the rising demand from several end-use sectors, such as construction, food and beverage, and pharmaceuticals, manufacturers in the calcium sulfate market are concentrating on creating high-quality goods. In order to lessen their influence on the environment and adhere to rules, they are also implementing sustainable production techniques. Also, to reach new markets and boost their market share, firms are extending their global reach through strategic alliances and acquisitions.

RECENT DEVELOPMENTS

  • In July 2022, Alberta-based CGC Inc., a Canadian unit of USG Corporation, aims to open a brand-new, slashing wallboard manufacturing facility in Wheatland County. This investment could further enable CGC to provide even greater service to its devoted customers in Alberta and the West, and it also demonstrates CGC’s commitment to the Canadian market.
  • In order to reduce the cost of building construction and boost productivity and speed of implementation, Jonoub Gypsum Co. started manufacturing its new product, “Mixed soil and gypsum (Soil Gypsum)” in July 2018.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Non-GMO Food Products Market Sets Sail for US$ 144,322 Million by 2031 A Global Perspective on Smart Labels Transparent Food Producers

Newly released data from the non-GMO food products market analyzed by FMI estimates that the non-GMO food products market enjoys a growth rate of 10.4% at present. The market is expected to witness a prominent growth rate of a CAGR of 13.2% to reach the value of US$ 144,322 Million in 2031.

The introduction of smart labels, which provide quick access to product-specific information, is another element fueling the expansion of transparent, non-GMO food producers across international borders. The market is expected to reach US$ 3.4 billion in value by the end of 2031.

Boost Your Understanding of the Market To discover more about the rapidly expanding non-GMO food product market, send an inquiry for a sample report to:
https://www.futuremarketinsights.com/reports/sample/rep-gb-11088

The demand from consumers for non-GMO food items will increase as a result of dietary trends including healthy eating and choosing natural food products, among other developments. An increase in health-related problems and growing knowledge of the negative effects of consuming genetically modified foods are the driving forces behind this transformation.

Key Takeaways of non-GMO Food Product Market Study

  • Grains and Cereals will dominate market demand with a multiplying growth rate of 22% through the end of 2029.
  • Bakery & Confectionary products present gainful opportunities with a stupendous growth rate of 19% during the forecast period.
  • Dairy products is another segment that will register a CAGR of 16% from 2019 to 2029.
  • Indirect distribution channels will maintain share-wide and growth-wise dominance throughout the forecast period.
  • North America and Latin America collectively account for more than half of total market value. This can be attributed to the early adopting nature of North American countries and rising millennial population in Latin America.

Consumer Preferences Shape Growth Trajectory

Increase in purchase potential and decrease in production costs is creating remunerative synergy in the market. This is fueled by advancements in packaging and labelling along with proactive consumer participation. Major players are investing in developing consumer communities that support long-term revenue generation.

The non-GMO food products industry is dependent on consumer awareness and prevalence of plant-based and vegan diets that require daily consumption of food products manufactured from non-genetically modified organisms.

Who’s Wining?

Competitive landscape in non-GMO food products industry is fragmented with the presence of multinationals, niche-manufacturers, and SMEs. Major players that shape the global non-GMO food products industry are Cargill, Inc., Associated British Foods Plc, General Mills Inc., Kraft Heinz, Archer Daniels Midland Company, Danone, Nestle S.A., The Hain Celestial Group Inc. Key players in the market are forging strategic partnerships that ensure sustained revenue prospects.

Spend money on market insights for non-GMO food products. Get It Now to Keep Up with Industry Trends and Rivals:
https://www.futuremarketinsights.com/checkout/11088

Market Segments Covered in Non-GMO food products Industry Analysis

By Nature :

  • Organic
  • Conventional

By Product :

  • Grain and Cereals
    • Wheat
    • Soya
    • Corn
    • Others
  • Bakery and Confectionery
    • Bread
    • Pastry
    • Candy
    • Others
  • Beverages
    • Alcoholic Beverages
    • Non-Alcoholic Beverages
  • Dairy Products
    • Yogurt
    • Cheese
    • Ice cream
    • Others
  • Infant Food
  • Condiment, Dressing, & Oil
    • Vegetable Oils
    • Jam, Jellies
    • Syrups
  • Others (Spices, soups, etc.)

By Distribution Channel :

  • Direct Sales/B2B
  • Indirect Sales/B2C
    • Supermarket/Hypermarket
    • Wholesaler
    • Online Retail
    • Specialty Stores
    • Other Retail Format

Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

All of the information is available to you! To obtain the complete report, contact one of our analysts:
https://www.futuremarketinsights.com/ask-question/rep-gb-11088

Key Questions Answered in the Report

How much is the Non-GMO food products market currently worth?

Non-GMO food products industry size is worth more than US$ 41,510 Mn.

At what CAGR is the market expected to grow?

Non-GMO food products consumption is expected to grow at a CAGR of around 13.2% during the period 2021-2031.

How was the performance in the last five years?

In terms of revenue non-GMO food products grew at a CAGR of around 10.4% during 2016-2020

What are the key trends boosting Non-GMO food product sales?

Non-GMO food products are gaining traction due to concerns over the effect of genetically modified foods on health, advanced technologies, shifting consumers’ preference towards healthy food products are the latest trends of non-GMO food products being observed in the market.

How are market players reacting to the new developments in the market?

Market companies are choosing to aim at research and development, consolidation of distribution channel in emerging countries, new product introductions to stay a noticeable player in the global market.

Which are the major countries driving demand for the Non-GMO food products Market?

The US, Russia, UK, China, Brazil, Germany, India are the major countries driving demand for non-GMO food products.

At what level does the report reflect pricing analysis?

The report presents a detailed cost analysis of non-GMO food products based on products i.e. grain and cereals, bakery & confectionery, beverages, dairy products, infant food, condiment, dressing, & oil, and others.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

 Contact Us:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Blood Coagulation Analyzers Industry Poised to Transform Medical Care, Projected at US$ 5,680.7 Million by 2033 According to FMI

The blood coagulation analyzers industry refers to the global industry that produces and sells devices used to analyze blood clotting or coagulation processes. These analyzers are essential in diagnosing and monitoring various bleeding disorders, thrombotic events, and coagulation abnormalities.

Key players in the blood coagulation analyzers industry develop and distribute devices that measure the clotting time, clotting factors, and other parameters related to coagulation. These analyzers are primarily used in hospitals, clinics, diagnostic laboratories, and research institutions.

Get your PDF Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-4524

By 2023, the market for blood coagulation analyzers is projected to be worth US$ 3,038.9 million, and by 2033, it is anticipated to be worth US$ 5,680.7 million. Blood coagulation analyzer sales are predicted to increase at a CAGR of 6.5% over the course of the projection period.

The market for blood coagulation analyzers has been experiencing steady growth in recent years due to several factors. These include:

  • Increasing prevalence of bleeding disorders and thrombotic events: The rising incidence of conditions such as hemophilia, von Willebrand disease, and deep vein thrombosis has created a demand for coagulation analyzers for accurate diagnosis and management.
  • Aging population: As the global population continues to age, the prevalence of coagulation disorders and related conditions increases. This drives the need for blood coagulation analyzers to monitor and manage these conditions effectively.
  • Technological advancements: Advances in technology have led to the development of more efficient and accurate coagulation analyzers. These devices provide faster results, improved precision, and enhanced automation, leading to increased adoption in healthcare settings.
  • Growing awareness and healthcare expenditure: Increased awareness about the importance of early diagnosis and management of bleeding and clotting disorders, along with higher healthcare spending in many countries, has contributed to the growth of the blood coagulation analyzers industry.
  • Expansion of point-of-care testing: Point-of-care testing (POCT) has gained popularity in recent years due to its convenience and rapid results. Blood coagulation analyzers suitable for POCT settings are being developed and adopted, further driving market growth.

Blood coagulation analyzers industry: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Blood coagulation analyzers industry. Competitive information detailed in the Blood coagulation analyzers industry report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Blood coagulation analyzers industry report.

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-4524

Key players covered in the report include:

  • Diagnostica Stago
  • NIHON KOHDEN CORPORATION
  • Helena Laboratories
  • Instrumentation Laboratory
  • International Technidyne Corporation
  • Roche Diagnostics
  • Danaher Corporation Abbott Laboratories

Important Questions Answered in the Blood coagulation analyzers industry Report

  • Which end user remains the top revenue contributor in different regional markets?
  • At what rate has the global Blood coagulation analyzers industry been expanding during the forecast period?
  • How will the global Blood coagulation analyzers industry look like by the end of the forecast period?
  • What innovative strategies are adopted by Blood coagulation analyzers industry players to stay ahead of the pack?
  • What are the restraints affecting the growth of the global Blood coagulation analyzers industry?

For More Report Customization, connect with us at! https://www.futuremarketinsights.com/customization-available/rep-gb-4524

Blood coagulation analyzers industry: Segmentation

Valuable information covered in the FMI’s Blood coagulation analyzers industry report has been segregated into key segments and sub-segments.

By Product:

  • Systems
  • Automated Systems
  • Semi-Automated Systems
  • Manual Systems
  • Reagents
  • Accessories

By Technology:

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology

By Test Type:

  • Prothrombin Time Testing
  • Fibrinogen Testing
  • Activated Clotting Time Testing
  • Activated Partial Thromboplastin Time Testing
  • D-Dimer Testing
  • Platelet Function Tests
  • Anti-Factor Xa Tests
  • Heparin & Protamine Dose Response Tests for ACT

By Distribution Channels:

  • Hospitals
  • Clinical Laboratories
  • Point-of-Care Testing

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Brain Tumors Treatment Industry is Expanding, Driven by the Increased Availability of Specific Drugs, Set to Surpass US$ 6,228.2 Million By 2033

The brain tumor treatment industry worldwide is anticipated to reach a market value of US$ 3,114.2 million in 2023 and US$ 6,228.2 million by 2033, registering a CAGR of 7.2% during the forecast period. Key factors that are anticipated to foster the expansion of the brain tumour diagnosis market globally include the rising prevalence of such malignancy and the expanding elderly population. Treatment for brain tumours saw a CAGR of 4.7% over the preceding ten years.

Brain tumor refers to an abnormal mass of tissue wherein the brain cells magnify and expand in an unbridled manner. Primary brain tumor makes up the majority of brain tumor incidences. For example, as per the study released by a Cancer Journal for Clinicians, in the year 2021, approximately 83,570 people were identified with brain tumors in the United States, from which primary brain tumors formed 70.3% of the cases. The rise in brain tumors can be attributed to a surging aging population, an accelerating rate of smokers, and increasing exposure to electromagnetic radiation.

Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-1302

Brain tumor contributes 1-2% of all cancer types. Moreover, the mortality rate for people suffering from this cancer is also high. Most of these cases are observed in North America and Asia Pacific. National Brain Tumor Society (NBTS) declared that it is offering funding worth US$ 1,00,000 to contribute toward the study conducted on the efficiency of CT-179, which is a novel drug candidate. This drug is expected to be a potential treatment for glioblastoma.

A growing pool of patients and a surging focus of key players toward research and development to launch advanced drugs with clinical advantages for the management of this condition is expected to fuel market growth.

Top Highlights from the FMI’s Analysis of the Brain tumor treatment industry:

  • North America’s brain tumor treatment industry has a massive stake in the market. In 2022, the region represented 34.2% market share, suggesting significant investment opportunities in the market.
  • Europe garnered a 24.2% value share in 2022 and is expected to observe an expansion in market size in the upcoming years. Surging investments in the healthcare sector and increasing cases of brain tumors are expected to attract key players in this market.
  • The United States’ stake in the market is significantly high, i.e., 30.2%. Increasing medical tourism to seek top-quality healthcare services is projected to accelerate market growth.
  • Germany held 5.1% of the market in 2022. The prominence of the country in Europe and the world over and the widespread prevalence of cancer cases have opened significant revenue-generating prospects for market participants.
  • China is expected to be the robust market for brain tumor treatment in the forecast period, luring manufacturers to expand and build capacities in the country.
  • India is another key market for brain tumor treatment in terms of CAGR. Over the forecast period, India is expected to observe a CAGR of 7.2%.
  • The United Kingdom registered a CAGR of 5.1% over the forecast period.
  • Based on product, the temozolomide segment captured 25.6% of the market share in 2022.
  • Under the category of end users, the hospital pharmacies segment gained a massive share of 44.8% in 2022.

Don’t Hesitate To Get In Touch With Our Analyst To Resolve Your Inquiries! https://www.futuremarketinsights.com/ask-question/rep-gb-1302

Key Developments in the Market:

  • To maximize the administration of certain psychedelic drug candidates, Nextage Therapeutics and MindMed signed an MOU in April 2021 that ascertains deployment of the patented Brain Targeting Liposome System (BTLS) delivery technology.
  • GenMarkDiagnostics and Roche came into a definitive merger agreement in March 2021 for Roche to entirely obtain GenMark for a value of US$ 24.05 per share in an all-cash transaction.

Key Companies Profiled:

  • Genentech USA
  • Bristol Myers Squibb
  • Hoffmann- La Roche
  • AstraZeneca Plc.
  • Pfizer Inc.
  • Novartis AG
  • Antisense Pharma
  • Merck & Co
  • MacLeod’s Pharmaceutical Limited
  • Mankind Pharma
  • Siemens Healthineers AG
  • Dr. Reddy’s Laboratories Ltd.

Ignite Innovation with Customization: Uncover the Possibilities in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-1302

Key Segments Covered in the Brain Tumor Treatment Industry Analysis:

By Product:

  • Temozolomide
  • Carmustine
  • Cisplatin
  • Bevacizumab
  • Geftinib
  • Erlotinib

By End User:

  • Hospital Pharmacies
  • Ambulatory Surgical Centers
  • Individual Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube